Bristol-Myers Squibb Co. (NYSE:BMY) on 06/13/2019 declared a dividend of $ 0.4100 per share payable on August 01, 2019 to shareholders of record as of July 05, 2019.

Bristol-Myers Squibb Co. (NYSE:BMY) has paid dividends since 1900, has a current dividend yield of 3.4432079792% and has increased its dividends for 9 successive years.

Bristol-Myers Squibb Co.'s market cap is $ 77,908,676,780 and has a PE ratio of 0.00. The stock price closed yesterday at $ 47.63 and has a 52 week low/high of $ 44.30 and $ 63.69.

Bristol-Myers Squibb is engaged in the discovery, development, licensing, manufacturing, marketing, distribution and sale of biopharmaceutical products. Co.'s products are sold worldwide, primarily to wholesalers, retail pharmacies, hospitals, government entities and the medical profession. Co. manufactures products in the U.S., Puerto Rico and in four foreign countries. Co. has products in the following therapeutic classes: oncology; cardiovascular; and immunoscience. Co.'s products include: Opdivo; Eliquis; Orencia; Sprycel; Yervoy; Empliciti; Baraclude; the Reyataz Franchise; the Sustiva Franchise; and the Hepatitis C Franchise.

For more information on Bristol-Myers Squibb Co. click here.